ABOUT PALLEOS
Palleos is a central European full-service Clinical Research Organization (CRO) focused on product development including pre-clinical consulting and clinical services for small to large scale trials. More than 70,000 patients in 300 sites have been treated throughout various indications.
The many years of experience of Palleos makes it possible to provide customized services during the start-up phase, followed by consulting and project management during the preclinical and clinical research phase.
Through our cutting-edge project management and working with our established network of collaborators, we accelerate the journey towards overcoming public health challenges, today and tomorrow. With strong local expertise and focus on quality, Palleos ensures seamless clinical trial conduct and drug registration, on time and within budget.
Palleos provides a full range of high-quality CRO services for Phase I-IV, BE and RWE studies, with expertise in 29 therapeutic areas. From initial planning to study closure, we offer comprehensive expertise across all facets of clinical research ensuring precision and tailored solutions for every stakeholder involved.
Full-service clinical study engagements
- Clinical Study Design Preparation
- Medical Writing
- Consulting and Regulatory Support
- Project Management and Monitoring
- Drug Safety and Pharmacovigilance
- Data Management
- Biostatistics
- Clinical Supply Services and Logistics
- Marketing Authorization
- GMP Inspection Support
FEATURED ARTICLES
-
![European Union Flag, compass-GettyImages-1090057126]( "Is Your Clinical Trial Portfolio CTIS Compliant?")
The Clinical Trials Regulation and its centralized digital platform, the Clinical Trials Information System (CTIS), are now mandatory. Are you prepared to navigate your next clinical trial in the EU?
-
![GettyImages-505936413 clinical trials]( "Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis")
Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.
-
![Europe Globe Map Data GettyImages REV-1319209608]( "The Central And Eastern Europe (CEE) Clinical Trials Report")
This 2024 Industry Pages report provides an in-depth examination of the Central and Eastern European (CEE) clinical trial strategy, highlighting its pivotal role in global drug development.
-
![Europe Globe Map Data GettyImages REV-1319209608]( "Your Guide To Clinical Trials In Central and Eastern Europe")
Explore this annual report that can assist decision-makers working to understand the clinical research market in Central and Eastern Europe.
-
![GettyImages-1341484868 rare disease]( "How To Boost Patient Recruitment In Rheumatology Using Digital Solutions")
Patient enrollment is one of the biggest challenges for clinical trials in rheumatology. This article explains how to accelerate recruitment and ensure retention using digital solutions.
-
![Scientist Research Data GettyImages-1140779713]( "Data Matters: Accelerating Dermatology Research With Precision!")
When deadlines are tight, execution matters. Find out how Palleos delivered critical data packages, statistical analysis, and regulatory-ready documentation—on time and with precision!
-
![knee-anatomy_154293453-thinkstock_450x300]( "How To Recruit 236 Patients In An Osteoarthritis Study On Time During The Peak Of The Pandemic")
A leading Eastern European contract research organization completed the recruitment of 236 subjects in a Phase 3 osteoarthritis study for Handok Inc. despite hurdles caused by the COVID-19 pandemic.
-
![iStock-1018003662-shadow-rescue-hero]( "Top Countries For Rescuing Your Clinical Study")
When your study is in trouble, choosing the right country can help get it back on track. While many countries can and should be considered, palleos healthcare discusses the countries they have experienced with regard to clinical trial rescue.
-
![GettyImages-1372189785 waiting room]( "Innovation Under Pressure: Navigating Clinical Trials Amid a Pandemic")
How do you complete a Phase 2b rheumatology study in three countries despite global lockdowns? Palleos cracked the code, achieving recruitment targets and regulatory approvals against all odds.
-
![Lung--Cancer-GettyImages-103990748]( "Meeting 100% Recruitment 7 Months Ahead Of Schedule")
Uncover the detailed outcomes of this extensive Phase 3 clinical trial on a new biosimilar for non-small cell lung cancer.
CONTACT INFORMATION
Palleos
Welfenstraße 2
Wiesbaden, 65189
GERMANY
Phone: +49 611 950190 0
Fax: +49 611 950190 29
Contact: info@palleos.com
